News

2017.12.25News Release

Maruho and RaQualia Enter License Agreement for Selective Sodium Channel Blocker

2017.11.30News Release

Maruho and Asahi Kasei Pharma Announce Phase 3 Clinical Study Results of Famciclovir for the Treatment of Recurrent Herpes Simplex

2017.09.07News Release

Maruho Launches Anti-Herpes Virus Agent "Amenalief^® Tab. 200mg" in Japan

2017.09.01News Release

Maruho Receives Manufacturing and Marketing Approval and Insurance Coverage for In Vitro Diagnostic "Derma Quick^® VZV"

2017.08.01News Release

Maruho Succeeds Manufacturing and Marketing Approval for Acne Vulgaris Treatment "Epiduo^® Gel"

2017.07.11News Release

Maruho Launches Topical Scalp Psoriasis Treatment "Comclo^® Shampoo 0.05%" in Japan

2017.07.07News Release

Maruho Succeeds Marketing Approval for Anti-Atopic Dermatitis Agent "Protopic^® Ointment" in Japan

2017.07.03News Release

Maruho receives manufacturing and marketing approval for Anti-Herpes Virus Agent "Amenalief^® Tab. 200mg" in Japan

2017.06.05News Release

Maruho and the Japanese Dermatological Association announce the Joint Operation of the Maruho Prize

2017.03.30News Release

Maruho receives manufacturing and marketing approval in Japan for Topical Scalp Psoriasis Treatment "Comclo^® Shampoo 0.05%"

2017.03.14News Release

Toray and Maruho Enter License Agreement for RORγt Inhibitor

2017.03.06News Release

Cutanea (Maruho's US Subsidiary) Unveils Aktipak™ (erythromycin and benzoyl peroxide) Gel, 3%/5%, Convenient Acne Treatment for "On-the-Go" Patients